Enterococcus faecalis: NCBI 1351, [species]

Back to details

| "Enterococcus proteiformis" Thiercelin and Jouhaud 1903| "Enterocoque" Thiercelin 1902| "Micrococcus ovalis" Escherich 1886| "Micrococcus zymogenes" MacCallum and Hastings 1899| "Streptococcus glycerinaceus" Orla-Jensen 1919| "Streptococcus liquefaciens" Sternberg 1892| ATCC 19433| ATCC 19433-U| CCUG 19916| CIP 103015| DSM 20478| Enterococcus faecalis| Enterococcus faecalis (Andrewes and Horder 1906) Schleifer and Kilpper-Balz 1984| Enterococcus proteiformis| Enterococcus sp. 7L76| Enterococcus sp. KB1| Enterocoque| HAMBI 1711| JCM 5803| JCM 8726| LMG 7937| LMG:7937| Micrococcus ovalis| Micrococcus zymogenes| NBRC 100480| NBRC 100481| NCAIM B.01312| NCDO 581| NCIMB 775| NCTC 775| Streptococcus faecalis| Streptococcus faecalis Andrewes and Horder 1906 (Approved Lists 1980)| Streptococcus glycerinaceus| Streptococcus liquefaciens

1. Probiotic Potential: Some strains of Enterococcus faecalis have been explored for potential probiotic properties. They might contribute to gut health by helping to maintain a balanced gut microbiota and support digestion.

2. Contribution to Gut Microbiota Diversity: Enterococcus faecalis, in its normal state, contributes to the diversity of the gut microbiota. A diverse microbiota is generally associated with better overall health.

3. Potential for Pathogenicity: Enterococcus faecalis is considered an opportunistic pathogen. In some cases, it can cause infections, especially in individuals with compromised immune systems or underlying health conditions. It's one of the bacteria responsible for certain urinary tract infections, endocarditis, and other nosocomial infections.

4. Antibiotic Resistance: Some strains of Enterococcus faecalis have developed resistance to antibiotics, which can pose challenges in clinical settings, particularly in healthcare-associated infections.

5. Role in Disease: While Enterococcus faecalis is a part of the healthy gut microbiota, alterations in its abundance or behavior have been associated with certain disease conditions. Changes in its population dynamics may be linked to conditions such as inflammatory bowel disease (IBD) or bacterial overgrowth in the gut.

6. Potential Applications in Medicine: Certain strains of Enterococcus faecalis have been used in the production of antibiotics and other biotechnological applications.

Other Sources for more information:

• Immune Epitope Database
• The NCBI taxonomy database
• UniProt
• Immune Epitope Taxonomy Database (IEDB)
• AI Engines For more Details: Perplexity  Kagi Labs  You 

Legend

• The interactions are based on data from 1000 healthy individuals using shotgun 10M reads Precision Biome, a provider in full conformity to EU regulations for health information
• The width of the lines indicates R² (the coefficient of determination)
• Green indicates positive slope
• Red indicates negative
• Interactions are not two way because incidence of each bacteria are different

Enterococcus faecalis impacts on other bacteria of the same rank

R2	Slope	Tax Name	Parent Chart
0.3268772065639496	0.45680952072143555	Peptoclostridium acidaminophilum	Parent Taxa
0.3028563857078552	-0.4813954830169678	Bradyrhizobium sp. BTAi1	Parent Taxa
0.1021924689412117	0.29388853907585144	Streptococcus lactarius	Parent Taxa

Other bacteria of the same rank impacting Enterococcus faecalis

R2	Slope	Tax Name	Parent Chart
0.1021924689412117	0.3477252721786499	Streptococcus lactarius	Parent Taxa